Cagrilintide
Synthetic amylin analogue, used in metabolic research.
- 1–2 pcs€120 each
- 3+ pcs€108 each−10%
- 10+ pcs€96 each−20%
- Certificate of analysis for every batch
- Over 99% verified purity
- Ships within 24 hours
- Free shipping over €250
Description and specifications
Description
Cagrilintide is a synthetic acylated amylin analogue. In research models, the molecule is studied for its role in appetite regulation, energy balance and interplay with incretin-based signalling pathways. Supplied as a lyophilised powder for reconstitution in the laboratory. For research use only (in vitro / laboratory use). Not for consumption, diagnostic or therapeutic use.
Research summary
Cagrilintide is a synthetic, long-acting analogue of the hormone amylin. Amylin is normally released together with insulin and is involved in satiety, appetite and how quickly nutrients leave the stomach. Research on cagrilintide is mostly about weight regulation, alone or together with semaglutide.
Level of evidence: The body of data for cagrilintide is still developing. Phase 2 and phase 3 studies in humans have been published, particularly for the combination with semaglutide. The studies concern controlled drug candidates, not openly available research products, and are largely manufacturer-sponsored.
This information is written for a laboratory and research context. The product is not intended for consumption, diagnostics or therapeutic use.
Specifications
| CAS | — |
| Molecular formula | C194H312N54O59S2 |
| Purity | ≥ 99 % (HPLC) |
| Size | 10 mg |
Batch information
Batch number, purity and document status are shown here for each published batch.
Need the certificate of analysis?
Contact ArcticAmino to receive a copy of the certificate of analysis (COA) for the product or batch.
Peptide guide
Research Use Only. Not for human consumption. Not medical advice. Always check information against primary sources and internal laboratory procedures.
Read the full guide (3 studies)Cagrilintide
Whereas GLP-1 analogues mainly mimic one incretin signal, cagrilintide mimics the amylin system. Studies investigate whether the amylin signal can reduce food intake and body weight, and whether the combination with semaglutide can produce a greater effect than either substance alone. This is clinical drug research, not documentation for the use of unregulated research products.
What is being researched?
- Weight reduction in adults with overweight or obesity
- The combination cagrilintide + semaglutide (CagriSema)
- Blood sugar and weight in people with type 2 diabetes
- Tolerability, side effects and pharmacokinetics in early-phase studies
Selected sources
How your order is handled
How an order moves from request to delivery.
Order
You send the order with the items and your contact details.
Approval
We review and approve the order.
Payment
You pay with your chosen payment method.
Delivery
The items are shipped in discreet packaging.
Why researchers choose ArcticAmino
- Certificate of analysis for every batch
- Over 99% verified purity
- Ships within 24 hours
- Ships within 24 hours
- Discreet packaging
- Customer service by email and Telegram
- Free shipping over €250
- For research purposes only
Often ordered together for lab set-ups.
